Brunner, Tobias M. http://orcid.org/0000-0002-5279-2391
Serve, Sebastian http://orcid.org/0000-0002-9839-7119
Marx, Anna-Friederike
Fadejeva, Jelizaveta
Saikali, Philippe http://orcid.org/0000-0002-4916-7376
Dzamukova, Maria http://orcid.org/0000-0002-2389-3222
Durán-Hernández, Nayar http://orcid.org/0000-0003-4253-0387
Kommer, Christoph
Heinrich, Frederik http://orcid.org/0000-0001-6097-5422
Durek, Pawel
Heinz, Gitta A. http://orcid.org/0000-0002-9330-3689
Höfer, Thomas http://orcid.org/0000-0003-3560-8780
Mashreghi, Mir-Farzin http://orcid.org/0000-0002-8015-6907
Kühn, Ralf http://orcid.org/0000-0003-1694-9803
Pinschewer, Daniel D. http://orcid.org/0000-0002-1594-3189
Löhning, Max http://orcid.org/0000-0001-6382-7281
Article History
Received: 24 January 2023
Accepted: 2 November 2023
First Online: 3 January 2024
Competing interests
: The authors declare the following competing interests: D.D.P. is a founder, shareholder and advisor to Hookipa Pharma, commercializing arenavirus vectors. The remaining authors declare no competing interests.